Blood Orange Kush (Cannabis flos Canopy Growth): lineage from Lemon Kush and limonene in the profile

Where does Blood Orange Kush come from and who provides its lineage?

Blood Orange Kush was created by crossing Lemon Kush with Guava Kush, and this lineage is provided by the official catalog of Canopy Growth, the owner of the Spectrum Therapeutics brand. In Polish pharmacies, the dried flower of this strain is issued under the commercial name containing Spectrum, so the patient primarily sees the manufacturer's brand on the packaging, rather than the cultivar name.

The term "kush" in the name tempts one to look for family ties. There are ten strains in this cluster that carry this term: half have established parents, while the other half do not have any at all (Hindu Kush, OG Kush, Pink Kush, Master Kush, and Afghan Kush). Blood Orange Kush belongs to the first group, but not because its name reveals anything, rather because the breeder described the cross directly on their own website. The common word does not prove kinship nor does it exclude it.

Neither Lemon Kush nor Guava Kush is available independently in the Polish pharmacy market, so the lineage cannot be verified by comparing it with parents available by prescription. What remains is the breeder's declaration and what follows from it for the description. The strain is classified as indica, but this classification comes from a single source and speaks more about how sellers organize their catalog than about the measured properties of the plant.

Who introduces this strain to Polish pharmacies?

One manufacturer. Blood Orange Kush enters the Polish market exclusively as dried flower from the Spectrum Therapeutics brand, which is the medical line of the Canopy Growth group. There is no second pharmacy version of this strain, so there is nothing to compare between suppliers: the differences that patients usually ask about simply do not arise.

One row in such a table is not a flaw in the comparison. For strains supplied by several manufacturers, the documentation of batches, packaging methods, and declared processing of the raw material are compared. Here, there is nothing to build such a comparison on, and it is more honest to write that than to fill in the columns with generalities about quality.

The exclusivity of the supplier has one more effect that is rarely discussed. A break in the supply chain or a change in the orders of wholesalers is enough for the strain to disappear from pharmacies for many weeks, while with several suppliers, the same cultivar could remain on the shelf. You can find the current status and how many items this manufacturer currently has in the comparison of currently available strains, a szerszy opis samego dostawcy zbiera osobny wpis o marce Spectrum Therapeutics.

What does the dried flower of this strain smell like?

Citrusy, with a distinct accent of bitter orange peel, against a backdrop of a milder floral and earthy note. At least that's how catalogs describe it, as aroma is not a quantity measured in the analysis certificate. The description of the scent remains a report from a person who experienced it, not a result that is repeatable between batches of raw material.

The terpene profile provides one source for this strain, the Polish database budcare.pl, and it lists limonene as the leading position, followed by linalool, a dalej myrcene. The first one is responsible for the citrus impression, the second adds a floral-lavender tone, and the third is earthy and slightly spicy. The commercial name suggests exactly the same association as the scent description, which can be misleading: names are arranged based on impression, not analytical results.

You won't find a single percentage next to the scent components, and this is a decision, not an oversight. Public listings for the Polish market sum up to 46, then to 73, and then to 83 percent, which only means that each counts differently and does not state what its fraction refers to. The order of positions in the profile carries information; a percentage next to the name would be a facade of precision.

When does the strain start to take effect and how long does it last?

The course is determined by the method of intake, and the cultivar takes a back seat here. No one has announced pharmacokinetic measurements for Blood Orange Kush, and in fact, none have been announced for any strain in this listing, so the ranges provided below describe the absorption of the dried flower and that's all that can be said on this topic.

The route of administration determines the course more than the variety itself. After vaporization, the substance passes from the lungs to the blood almost immediately, so the first sensations appear after a few minutes, the intensity increases for another ten to thirty minutes, and the whole effect lasts for two to four hours. After ingestion, the raw material first passes through the intestine and liver, so the first sensations are awaited from half an hour to two hours, and the episode can last six, sometimes eight hours. Hence the most common mistake with oral administration: anyone who thinks nothing is happening after thirty minutes and takes another dose will receive both doses at once. The above ranges describe the route of administration, not this variety; pharmacokinetic studies for a single cultivar have not been published.

For this strain, there is one practical caveat: the method of intake is determined by the attending physician, not the description in the seller's catalog, and it is the physician who decides whether the above ranges are at all relevant for the patient.

What has really been shown in studies on the leading terpene?

Two studies on rodents, and nothing more. Both available studies concern isolated limonene administered to animals via injection, not the dried flower of Blood Orange Kush inhaled by patients. They describe the property of a single molecule under laboratory conditions, rather than the effect one might expect from this strain.

An earlier position is a work by Vale and colleagues, published in 2002 in the journal "Phytomedicine" (PMID:12587690). Mice were injected with limonene into the peritoneal cavity. A dose of 50 mg/kg was sufficient to impair their balance in the rota-rod test, and the authors interpreted this result as muscle relaxation; a dose four times greater prolonged sleep after pentobarbital by approximately 2.6 times. Separately, a trial was conducted in an elevated plus maze: already 5 mg/kg was enough for the animals to venture less into the open arms, and the researchers termed this result anxiogenic.

A more recent study from 2025 was published in the journal "Behavioural Pharmacology" (Fakhri et al., PMID:40622197). Here, limonene reduced paw swelling in rats after carrageenan administration, and in mice, it suppressed pain responses in the formalin test. The authors identified the mechanism as a signaling pathway leading from l-arginine through nitric oxide to cGMP, along with KATP channels, attributing a role to opioid and benzodiazepine receptors as well.

No anxiolytic effect of limonene has been demonstrated in humans. It has also not been shown that isolated limonene acts anxiolytically in animals; the only available data from the elevated plus maze test showed an opposite effect in mice, reducing the number of entries into the open arms even at a low dose.

The rest of what circulates about the strain has a completely different status. The profile composition is described by one source, so there is nothing to compare it with or confirm it, and descriptions of the effects of this strain come from patient reports and materials from sellers and are not data. A broader discussion of the terpene itself is collected in a separate entry about limonenie.

What side effects have been reported after this strain?

None. Not due to the exceptional mildness of this dried flower, but because the pharmacotherapy safety registry assigns reports to the medicinal product along with its batch, and the cultivar name is not a unit in it. Therefore, no separate compilation for Blood Orange Kush is conducted, and the rest of the section speaks about the raw material.

Reports of adverse effects are collected for medicinal products with a batch number, not for the strain name, so the following pertains to hemp dried flower as a group of raw materials. The most frequently reported symptoms are dry mouth, red eyes, and increased heart rate. Dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory are less frequently described, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp dried flower in Poland do not separate them by individual products.

One caveat concerns this strain directly. Since it is supplied by a single manufacturer, any potential report will go into the documentation of one product and will not be distributed across several pharmacy versions bearing the same strain name.

Can the vaporization temperature be adjusted for limonene?

Not in the way suggested by popular tables. Vaporization does not start only at the boiling point; it increases gradually with temperature, and the value set on the device describes the heating element or air, not the dried flower itself. Therefore, targeting a single molecule is based on a misunderstanding.

For this strain, the data appears unusually favorable. All three entries from its profile fall within the top six terpenes for which the PubChem database assigns a boiling point along with the pressure at which it was measured; out of eleven terpenes present in this project, only this many have records suitable for comparison with others. For comparison, humulene was measured at a pressure of 3 mm Hg, nearly in a vacuum, and for bisabolol and farnesene, the database does not provide a boiling point at all.

However, no recommendations arise from comparable numbers. How much terpene actually reaches the lungs and blood in humans has not been measured, and the method of administration is determined by the attending physician, as the raw material seems to come from a doctor's prescription. The mechanism of evaporation and the reasons why the temperature tables contradict each other are detailed in a separate entry about the evaporation of terpenes from dried flower.

Which cultivars from Polish pharmacies are its siblings?

None. The pedigree chart of this compilation does not indicate a single strain available in Polish pharmacies that shares a parent with Blood Orange Kush. Lemon Kush and Guava Kush are not issued separately here, and their other offspring have not entered the Polish market.

An empty sibling list with a known pedigree can be a correct result, not a gap in the data. Kinship arises when two cultivars share an identified parent present in the same compilation; broad families of styles or landraces do not create such bonds, as they are categories, not individual strains. Adding neighbors by intuition would create false connections between parties.

In the catalog, however, there are eight strains from the same manufacturer side by side, and it is easy to confuse this proximity with kinship. A common supplier describes the supply chain, not the plant's genetics, just as a recurring term in the trade name does. A patient looking for something with a similar character has nothing to grasp on the pedigree side and is left with a comparison based on the terpene profile, which relies on a single source, or simply a conversation with the attending physician. The only thing known for sure about the origin of this strain is recorded by the breeder, and with that statement, the topic closes.

Frequently Asked Questions about Blood Orange Kush

Is Blood Orange Kush an indica strain?

One source describes it as such, and only on that basis. The classification as an indica type comes from the seller's catalog, not from measurement, so it is more of a label organizing the list than a feature of the plant confirmed by research.

Under what name will I find this strain in the pharmacy?

Under the trade name with the Spectrum component. In the Polish market, the dried flower of this strain comes exclusively from Spectrum Therapeutics, the medical brand of the Canopy Growth group, and this brand is prominently displayed on the packaging.

What terpenes are described in the profile of this strain?

Limonene as the leading position, alongside linalool and myrcene. We provide the composition without percentage shares, as the sources do not disclose what their numbers refer to, and their sums do not agree between databases.

Does limonene have anxiolytic effects?

This has not been demonstrated in humans. In the only available test on mice, isolated limonene reduced the number of entries into the open arms of the maze, which the authors described as an effect opposite to anxiolytic.

Does the Kush part in the name indicate kinship with other Kush strains?

No. In this comparison, ten cultivars have this component in their name, and half of them have no established parents at all. A common word in the name is not evidence of kinship in any direction.

Is Blood Orange Kush consistently available in pharmacies?

There is no such guarantee with a single supplier. A break in supply or a change in the wholesaler's orders can remove a strain from the shelf for many weeks, and the current state is summarized by the list of currently available strains.

Dried flower is a pharmaceutical raw material dispensed exclusively by prescription from a doctor in the Rpw category. The above text is for informational purposes only, does not replace medical consultation, and is not an encouragement to use. The material was prepared by redakcja ubucha.pl.